Skip to main content
Advertisement

< Back to Article

Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: An open randomized controlled phase IIb clinical trial

Fig 3

Primary efficacy endpoint analysis in Bothrops snakebites.

Clotting time, fibrinogen and INR levels 24 hours after AV therapy in freeze-dried trivalent antivenom (FDTAV) and Ministry of Health standard liquid antivenoms (SLAVs) treated groups.

Fig 3

doi: https://doi.org/10.1371/journal.pntd.0006068.g003